Agile Therapeutics, Inc. (OTCQB: AGRX), relating to its proposed merger with Insud Pharma, S.L. Under the terms of the agreement, Agile Therapeutics shareholders will receive $1.52 per share of Agile stock they own in cash.
Agile Therapeutics, Inc. (OTCQB: AGRX), relating to its proposed merger with Insud Pharma, S.L. Under the terms of the agreement, Agile Therapeutics shareholders will receive $1.52 per share of Agile stock they own in cash.